Edition:
India

Champions Oncology Inc (CSBR.OQ)

CSBR.OQ on NASDAQ Stock Exchange Capital Market

6.18USD
16 Aug 2019
Change (% chg)

$0.31 (+5.19%)
Prev Close
$5.88
Open
$5.96
Day's High
$6.18
Day's Low
$5.96
Volume
3,168
Avg. Vol
7,011
52-wk High
$17.89
52-wk Low
$5.25

Latest Key Developments (Source: Significant Developments)

Champions Oncology Reports Q1 Revenue Rose 23.7 Pct To $6.2 Mln
Friday, 14 Sep 2018 

Sept 13 (Reuters) - Champions Biotechnology Inc ::CHAMPIONS ONCOLOGY REPORTS RECORD QUARTERLY REVENUE OF $6.2 MILLION.Q1 REVENUE ROSE 23.7 PERCENT TO $6.2 MILLION.SEES FY 2019 REVENUE UP AT LEAST 20 PERCENT.CHAMPIONS BIOTECHNOLOGY INC QTRLY GAAP EARNINGS PER SHARE $0.04.CHAMPIONS BIOTECHNOLOGY INC - REITERATED FORECAST OF REVENUE GROWTH IN FISCAL 2019.CHAMPIONS BIOTECHNOLOGY INC QTRLY NON-GAAP EPS $0.05.  Full Article

Champions Oncology QTRLY Loss Per Share GAAP $0.06
Friday, 27 Jul 2018 

July 26 (Reuters) - Champions Biotechnology Inc ::CHAMPIONS ONCOLOGY REPORTS RECORD ANNUAL REVENUE EXCEEDING $20M FOR FISCAL YEAR ENDED APRIL 30, 2018.Q4 REVENUE ROSE 32.3 PERCENT TO $4.9 MILLION.CHAMPIONS BIOTECHNOLOGY INC - QTRLY LOSS PER SHARE - GAAP $0.06.CHAMPIONS BIOTECHNOLOGY INC - QTRLY LOSS PER SHARE NON-GAAP $0.04.  Full Article

Champions Oncology Reports Quarterly Revenue Of $5.1 Million
Friday, 16 Mar 2018 

March 15 (Reuters) - Champions Biotechnology Inc ::CHAMPIONS ONCOLOGY REPORTS QUARTERLY REVENUE OF $5.1 MILLION.Q3 REVENUE ROSE 42.6 PERCENT TO $5.1 MILLION.SEES FY 2018 REVENUE UP AT LEAST 20 PERCENT.CHAMPIONS BIOTECHNOLOGY INC QTRLY LOSS PER SHARE ‍$0.01​.  Full Article

Champions Oncology Reports Record Quarterly Revenue Of $5.2 Million
Friday, 8 Dec 2017 

Dec 7 (Reuters) - Champions Biotechnology Inc ::CHAMPIONS ONCOLOGY REPORTS RECORD QUARTERLY REVENUE OF $5.2 MILLION.Q2 REVENUE ROSE 16.7 PERCENT TO $5.2 MILLION.SEES FY 2018 REVENUE UP AT LEAST 20 PERCENT.CHAMPIONS BIOTECHNOLOGY INC - REITERATED EXPECTATIONS FOR FISCAL YEAR 2018 REVENUE GROWTH OF AT LEAST 20% OVER FISCAL YEAR 2017.CHAMPIONS BIOTECHNOLOGY INC - QTRLY LOSS PER SHARE $0.01.CHAMPIONS BIOTECHNOLOGY - REITERATES POSITION THAT "IT DOES NOT CURRENTLY INTEND TO RAISE CAPITAL IN THE EQUITY MARKET".  Full Article

Champions Biotechnology reports Q1 loss per share $0.06
Friday, 15 Sep 2017 

Sept 15 (Reuters) - Champions Biotechnology Inc :Champions Oncology reports record quarterly revenue of $5 million.Q1 revenue rose 37.1 percent to $5.0 million.Sees fy 2018 revenue up at least 20 percent.Champions Biotechnology Inc - reiterated expectations for fiscal year 2018 revenue growth of at least 20 pct over fiscal year 2017.Champions Biotechnology Inc qtrly loss per share $0.06.Champions Biotechnology Inc qtrly adjusted loss per share $0.01.  Full Article